Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results

Edgewell posts strong adjusted earnings but GAAP profit hit by $101.8M restructuring costs.

What the company is saying

Edgewell Personal Care Company reports fourth quarter net sales of $484.1 million, up 3.0%, and full-year net sales of $1,996.5 million, up 1.8%. The company emphasizes adjusted EPS growth to $0.78 for the quarter and $1.93 for the year, highlighting a 50% quarterly increase and a 6.6% annual rise. Management, led by CEO Rod Little, frames the year as one of 'meaningful progress and change,' citing improved North America performance, a return to growth internationally, and stronger focus brand results. The narrative stresses successful delivery on adjusted top- and bottom-line targets, attributing gains to investments in innovation, brand building, and commercial execution. The company acknowledges persistent cost and competitive headwinds but asserts that operating model transformation is enabling greater investment capacity and more consistent growth. Forward-looking guidance for fiscal 2027 projects continued organic net sales and adjusted earnings growth.

What the data suggests

Fourth quarter net sales rose to $484.1 million, a 3.0% increase, with organic sales up 3.1%. Full-year net sales reached $1,996.5 million, up 1.8%, but organic growth was just 0.3%. Adjusted EPS climbed to $0.78 for the quarter and $1.93 for the year, while GAAP EPS was $0.23 for the quarter and a loss of $(0.05) for the year, reflecting $101.8 million in restructuring costs. Gross profit for the quarter was $209.6 million, with gross margin at 43.3%, and adjusted gross margin at 45.7%. Operating income for the year dropped to $41.4 million from $110.2 million, and cash from operations fell to $49.6 million from $118.4 million. The company ended the quarter with $375.6 million in cash and $418.8 million in credit facility access. Segment data show modest Wet Shave growth and a sharp profit rebound in Sun and Skin Care. The company returned $6.9 million in dividends in Q4 and declared a $0.15 per share dividend. Fiscal 2027 guidance targets 0.4–2.4% reported net sales growth, 1.0–3.0% organic growth, GAAP EPS of $0.90–$1.20, and adjusted EPS of $1.85–$2.15. The data show improved adjusted profitability but weak GAAP results due to restructuring, with only modest underlying sales growth.

Analysis

The announcement is a comprehensive quarterly and annual financial disclosure, with the majority of claims supported by realised, audited figures for sales, earnings, margins, and cash flow. The tone is factual and avoids promotional language, focusing on both GAAP and adjusted results. While the company reports significant restructuring and transformation costs ($101.8 million), these are transparently disclosed and tied to specific operational actions (Mexico facility and Wet Shave consolidation). The only forward-looking claims are the fiscal 2027 outlook ranges, which are clearly separated from realised results and not presented as achievements. The capital intensity flag is set due to the large restructuring outlays, but these are already incurred and not paired with exaggerated future benefit claims. There is no evidence of narrative inflation or overstatement; the language is proportionate to the mixed operational and financial results.

Risk flags

• ●Large restructuring and related costs totaling $101.8 million have driven GAAP net earnings negative for the year, raising questions about the pace and effectiveness of transformation initiatives. If cost savings and operational improvements do not materialize as planned, future profitability could remain under pressure.
• ●Cash flow from operations declined sharply to $49.6 million from $118.4 million, indicating potential strain on liquidity and the need for improved working capital management post-divestiture. Sustained weak cash generation could limit flexibility for investment or shareholder returns.
• ●Underlying organic net sales growth is minimal at 0.3% for the year, suggesting that top-line momentum is weak and reliant on successful brand execution and market share gains. Failure to accelerate organic growth could constrain margin expansion and long-term value creation.
• ●Adjusted results show improvement, but the gap between GAAP and adjusted metrics is wide due to restructuring and transformation charges. Heavy reliance on adjusted figures may obscure the true underlying earnings power if one-time costs persist or recur.
• ●Guidance for fiscal 2027 projects only modest sales and earnings growth, with continued headwinds from cost inflation and competition. If macroeconomic or industry conditions worsen, achieving these targets may prove challenging.

Bottom line

Edgewell's fiscal 2026 results show strong adjusted earnings growth and improved margins, but GAAP profitability is undermined by $101.8 million in restructuring and transformation costs. Cash flow from operations has fallen sharply, and organic sales growth remains sluggish at 0.3% for the year. The company is betting on operational transformation and brand investment to drive future gains, but the gap between adjusted and GAAP results highlights ongoing execution risk. Fiscal 2027 guidance is for modest growth, with management confident but facing persistent cost and competitive challenges. Investors should focus on whether restructuring delivers sustainable margin and cash flow improvement, and whether organic sales growth can accelerate. The most important takeaway is that while adjusted performance is improving, real value creation depends on translating transformation efforts into consistent GAAP profitability and cash generation.

Announcement summary

(NYSE:EPC) Edgewell Personal Care Company announced its results for the fourth fiscal quarter and full fiscal year ended September 30, 2026. Fourth quarter net sales were $484.1 million, representing a 3.0% increase compared to the prior year quarter. Full year net sales were $1,996.5 million, up 1.8% from the prior year. Organic net sales increased 3.1% for the quarter and 0.3% for the full year. GAAP diluted net earnings per share from continuing operations were $0.23 for the quarter, compared to $0.26 in the prior year quarter, and $(0.05) for the full year, compared to $0.93 in the prior year. Adjusted EPS was $0.78 for the quarter, up from $0.52 in the prior year quarter, and $1.93 for the full year, up from $1.81 in the prior year. The company ended the fourth quarter with $375.6 million in cash on hand and access to an additional $418.8 million under its U.S. revolving credit facility. Dividends totaling $6.9 million were returned to shareholders in the fourth quarter, and the Board declared a cash dividend of $0.15 per common share on November 12, 2026. Gross profit for the quarter was $209.6 million, up from $188.4 million in the prior year quarter, with gross margin at 43.3%. Adjusted gross margin increased to 45.7%. Advertising and sales promotion expense was $56.1 million, or 11.6% of net sales, up from $45.9 million in the prior year quarter. SG&A expense was $107.2 million, or 22.1% of net sales, compared to $105.5 million, or 22.5% in the prior year quarter. The company recorded pre-tax restructuring and related costs of $29.9 million in the quarter. Operating income was $16.9 million, or 3.5% of net sales, compared to $6.9 million, or 1.5% in the prior year quarter. Adjusted operating income was $51.1 million, or 10.6% of net sales, compared to $27.7 million, or 5.9% in the prior year quarter. Interest expense was $15.0 million, compared to $14.8 million in the prior year quarter. Other (income) expense, net was income of $8.3 million, compared to expense of $2.1 million in the prior year quarter. Adjusted other (income) expense, net was income of $8.7 million, compared to expense of $2.9 million in the prior year quarter. The effective tax rate for fiscal 2026 was (175.3)%, compared to (19.1)% in the prior year period. Adjusted effective tax rate for fiscal 2026 was 23.0%, compared to 11.0% in the prior year period. Adjusted net earnings from continuing operations were $36.8 million, or $0.78 per share, compared to $24.3 million, or $0.52 per share, in the prior year quarter. Adjusted EBITDA was $76.8 million, compared to $43.0 million in the prior year quarter. Net cash provided by operating activities was $49.6 million for the year ended September 30, 2026, compared to $118.4 million in the prior year period. Adjusted net debt leverage ratio at the end of the fourth quarter was 3.4x. Wet Shave segment net sales increased $3.9 million, or 1.2%, and organic net sales increased $5.2 million, or 1.6%. Wet Shave segment profit increased $5.7 million, or 10.8%. Sun and Skin Care segment net sales increased $10.3 million, or 7.0%, and organic net sales increased $9.5 million, or 6.5%. Sun and Skin Care segment profit increased $14.7 million, or 294.0%. For the full year, gross profit was $830.0 million, compared to $847.8 million in the prior year. Gross margin was 41.6%, down 160 basis points. Adjusted gross margin was 43.4%, down 10 basis points. A&P was $243.5 million, or 12.2% of net sales, up $15.6 million from the prior year. SG&A was $428.9 million, or 21.5% of net sales, compared to $408.6 million, or 20.8%, in the prior year. The company recorded pre-tax restructuring and related costs of $101.8 million for the year, including $80.0 million related to the consolidation of its Mexico facilities and Wet Shave operations, and $21.8 million related to global transformation actions. Operating income for the year was $41.4 million, or 2.1% of net sales, compared to $110.2 million, or 5.6%, in the prior year. Adjusted operating income was $161.6 million, or 8.1% of net sales, compared to $173.3 million, or 8.8%, in the prior year. Other (income) expense, net was income of $26.7 million, compared to income of $0.2 million in the prior year. Adjusted other (income) expense, net was income of $24.9 million, compared to expense of $3.0 million in the prior year. GAAP net (loss) earnings from continuing operations were $(2.2) million, or $(0.05) per diluted share, compared to $44.3 million, or $0.93 per diluted share, in the prior year. Adjusted net earnings were $90.5 million, or $1.93 per share, compared to $86.3 million, or $1.81 per share, in the prior year. Adjusted EBITDA was $254.5 million, compared to $239.7 million in the prior year. As of September 30, 2026, the company had approximately $85 million available for share repurchase under the Board's 2025 authorization. For fiscal 2027, the company expects reported net sales to increase approximately 0.4% to 2.4%, organic net sales to increase approximately 1.0% to 3.0%, GAAP EPS to be in the range of $0.90 to $1.20, adjusted EPS to be in the range of $1.85 to $2.15, adjusted operating margin to increase approximately 70 basis points, adjusted EBITDA to be in the range of $250 to $270 million, other income, net to be approximately $13 million, interest expense to be approximately $67 million, adjusted effective tax rate to be approximately 24%, capital expenditures to be approximately 2.75% to 3.25% of net sales, and adjusted free cash flow to be approximately $100 to $120 million.

Disagree with this article?